Astrazeneca

Logo GlobeNewswire
SciencePress Release2023-03-24 11:00:00
TREK-AD Phase 2b study of eblasakimab fully enrolled, topline data readout expected early July 2023 Phase 2 proof-of-concept trial of farudodstat in alopecia...

Logo Benzinga
Business / FinanceBy Globe Newswire2023-03-24 11:00:00
TREK-AD Phase 2b study of fully enrolled, topline data readout expected early July 2023 Phase 2 proof-of-concept trial of in alopecia areata expected to...

Logo PR Newswire
HealthPress Release2023-03-22 23:15:00
DUBLIN, March 22, 2023 /PRNewswire/ -- The "Diabetes Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...

Logo Nasdaq
TechnologyBy Zacks2023-03-24 10:55:00
For Immediate Release Chicago, IL March 24, 2023 Stocks in this weeks article are ASE Technology Holding Co., Ltd. ASX, Weatherford International plc WFRD,...

Logo GlobeNewswire
SciencePress Release2023-03-24 06:00:00
Emmanuel Hanon, PhD, will chair the companys scientific advisory board. Professor Peter Piot (MD, PhD) and Professor Patrick Soentjens (MD, PhD) have been...

Logo GlobeNewswire
SciencePress Release2023-03-23 20:15:00
CHATHAM, N.J., March 23, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-03-24 11:05:00
Ascend expands its presence in the Great Lakes State with its eighth dispensary in Michigan NEW YORK, March 24, 2023 /PRNewswire/ - Ascend Wellness Holdings,...

Logo PR Newswire
TechnologyPress Release2023-03-23 13:00:00
COLUMBUS, Ga., March 23, 2023 /PRNewswire/ -- Aspirion, a leader in technology-enabled healthcare revenue cycle management, announced today that it has named...

Logo PR Newswire
HealthPress Release2023-03-23 23:41:00
DUBLIN, March 23, 2023 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings...

Logo GlobeNewswire
SciencePress Release2023-03-23 20:05:00
On track to complete enrollment in Phase 2/3 LIFT-AD trial of fosgonimeton for mild-to-moderate Alzheimers disease in mid-2023 with topline data in early...

Logo EIN Presswire
HealthPress Release2023-03-24 13:41:23
CAMBRIDGE, MA, UNITED STATES, March 24, 2023/ EINPresswire.com / -- Alphageneron Pharmaceuticals, Inc., (Alphageneron or the Company), a clinical-stage...

Logo Nasdaq
TechnologyBy Zacks2023-03-23 11:28:00
For Immediate Release Chicago, IL March 23, 2023 Zacks Equity Research shares Asure Software ASUR as the Bull of the Day and CF Industries CF as the Bear of...

Logo The Business Journals
Technology2023-03-23 20:38:28
Moleculin is pushing its chemotherapy drug Annamycin into a second phase of clinical trials, with officials confident its data can lead to FDA approval.

Logo GlobeNewswire
SciencePress Release2023-03-24 07:00:00
LONDON and NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (OKYO or the Company), an ophthalmology-focused...

Logo PR Newswire
HealthPress Release2023-03-24 16:20:00
Bakery-inspired flavor joins lineup of industry-leading products with new WHEY and VEGAN proteins PITTSBURGH, March 24, 2023 /PRNewswire/ -- If you're in...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-23 20:28:00
Science Applications International Corp. (NYSE: SAIC ) announced today that it has signed a definitive agreement to sell its logistics and supply chain...

Logo Nasdaq
TechnologyBy Zacks2023-03-24 11:07:00
For Immediate Release Chicago, IL March 24, 2023 Today, Zacks Equity Research discusses for Chemed Corp. CHE, Addus HomeCare Corp. ADUS, RadNet, Inc. RDNT...

Logo GlobeNewswire
TechnologyPress Release2023-03-24 17:00:00
Villers-ls-Nancy, 24 March 2023 - 6:00 p.m. (CET) PRESS RELEASE 2022 Net Profit: +18.35% to 48.70m Revenue: +10.88 % to 214.07m. Strong growth driven by the...

Logo PR Newswire
HealthPress Release2023-03-24 12:54:00
LOS ANGELES, March 24, 2023 /PRNewswire/ -- Waismann Method®, a reputable addiction treatment center, is calling for urgent nationwide action to address the...

Logo GlobeNewswire
SciencePress Release2023-03-24 11:00:00
Company teams up with Novartis on Lipoprotein(a) education for 23andMe customers SOUTH SAN FRANCISCO, Calif., March 24, 2023 (GLOBE NEWSWIRE) -- In support...